Repurposed Drugs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
324
NCT05706454
Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
Phase: Phase 2/3
Role: Lead Sponsor
Start: Nov 10, 2022
Completion: May 31, 2026
Loading map...